Hikma Pharmaceuticals Plc Director/PDMR Shareholding (5260N)
20 Maggio 2020 - 04:42PM
UK Regulatory
TIDMHIK
RNS Number : 5260N
Hikma Pharmaceuticals Plc
20 May 2020
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 20 May 2020: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards on 16 May 2018 under the 2014 Executive
Incentive Plan ("EIP") Element B which was completed on 19 May
2020.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 16,953
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 22,601
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 15,855
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 25,729
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 23,062
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Brian Hoffmann
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from vesting of the conditional
transaction awards on
18 May 2020 under the 2014 EIP Element B.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 18,247
d) Aggregated information N/A
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Disposal of Shares acquired from vesting of
transaction the conditional awards on 18 May 2020 under
the 2014 EIP Element B.
c) Price(s) and Price(s): GBP24.629
volume(s) Volume(s): 13,489
d) Aggregated information Aggregated volume: 13,489
Price: GBP332,220.58
e) Date of the transaction 19 May 2020
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBSGDUGSDDGGG
(END) Dow Jones Newswires
May 20, 2020 10:42 ET (14:42 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024